Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS
Sponsor: Stony Brook University
Summary
The goal of this clinical trial is to learn if the OTC supplement, hydrogen water, works to treat the fatigue-related symptoms and functional limitations in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). It will also examine if heart rate variability (HRV) can be used to predict who will benefit from the hydrogen water treatment. The main questions it aims to answer are: Does the OTC supplement, hydrogen water, work to reduce the fatigue-related symptoms and improve functioning in participants who have ME/CFS? Can HRV be used to predict who will benefit from treatment with hydrogen water?
Official title: Heart Rate Variability as an Autonomic Marker of Improvement in ME/CFS in a Hydrogen Water Treatment Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-06-09
Completion Date
2026-05-31
Last Updated
2025-06-08
Healthy Volunteers
No
Conditions
Interventions
Hydrogen water which is prepared from an OTC supplement.
The intervention is hydrogen water which is prepared from an OTC supplement. It involves measurement of heart rate variability.
Locations (1)
Stony Brook University
Stony Brook, New York, United States